ARTECOM Trademark

Trademark Overview

On Wednesday, October 28, 2009, a trademark application was filed for ARTECOM with the United States Patent and Trademark Office. The USPTO has given the ARTECOM trademark a serial number of 77858981. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, June 6, 2011. This trademark is owned by Shin Poong Pharmaceutical Co., Ltd.. The ARTECOM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-malaria preparations, pharmaceuticals for treating infectious disease, anti-infective combination preparations, anti-parasitic preparations
artecom

General Information

Serial Number77858981
Word MarkARTECOM
Filing DateWednesday, October 28, 2009
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, June 6, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-malaria preparations, pharmaceuticals for treating infectious disease, anti-infective combination preparations, anti-parasitic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, June 6, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShin Poong Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAnsan-si 425-100
KR
Party NameShin Poong Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAnsan-si 425-100
KR

Trademark Events

Event DateEvent Description
Monday, June 6, 2011ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Monday, June 6, 2011ABANDONMENT - AFTER PUBLICATION
Tuesday, May 31, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, May 4, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2011PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 15, 2011ASSIGNED TO LIE
Tuesday, March 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, March 15, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 15, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, March 15, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, March 14, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 14, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 14, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 26, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 26, 2010INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 26, 2010SUSPENSION INQUIRY WRITTEN
Monday, April 26, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 26, 2010LETTER OF SUSPENSION E-MAILED
Monday, April 26, 2010SUSPENSION LETTER WRITTEN
Friday, April 23, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 23, 2010ASSIGNED TO LIE
Monday, April 12, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 2, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 2, 2010NON-FINAL ACTION E-MAILED
Tuesday, February 2, 2010NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2010ASSIGNED TO EXAMINER
Monday, November 2, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 31, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

artecom preparations anti disease infective combination infectious parasitic pharmaceuticals namely malaria